“Optimal 25(OH)D concentrations for colorectal cancer risk reduction, 75 to 100nmol/L, appear higher than current Institute of Medicine recommendations,” the authors write.
Your search for colorectal cancer returned 682 results
Adults aged 45 years and older with an average CRC risk are advised to undergo regular screening with a high-sensitivity stool-based test or structural (visual) examination, depending on patient preference and availability of the tests.
Higher empirical dietary inflammatory pattern score linked to increased risk of CRC for men and women
Liquid biopsy that identifies circulating tumor cells in a blood sample has high accuracy for detecting colorectal cancer.
In the Phase 2, multicenter, open-label, single-arm CheckMate -142 trial (n=74), qualified patients received Opdivo 3mg/kg intravenously (IV) every 2 weeks.
The researchers administered detailed epidemiologic questionnaires to 2,419 patients age 18 to 74 years with incident invasive CRC, diagnosed from 1997 to 2008.
Opdivo, a human programmed death receptor-1 (PD-1)-blocking antibody, is already indicated for various renal and urologic cancers, head and neck cancer, lymphoma, skin cancer, and lung cancer.
Colorectal cancer (CRC) rates among those aged 50 and older have fallen 32% since 2000, while deaths from the disease fell by 34%, according to a report published online March 1 in CA: A Cancer Journal for Clinicians.
The efficacy of NSAIDs, aspirin, and supplements in preventing the recurrence of advanced neoplasia after polyp removal was evaluated in a new study.
The American Academy of Family Physicians (AAFP) has graded the recommendation for colorectal cancer screening as a B recommendation, in contrast to the U.S. Preventive Services Task Force (USPSTF) grade A recommendation.